Minerva Neurosciences

Preço das Ações
6.33
Mudança Diária
0.02 0.32%
Mensal
46.53%
Anual
222.96%
Q1 Previsão
2.46




Ebitda Alterar Data
Acadia Pharmaceuticals USD 35.76M 447K 2025-09
Adma Biologics USD 58.74M 14.75M 2025-09
ALKERMES USD 121.55M 4.99M 2025-09
Alterity Therapeutics Limited AUD -7.72M 2.99M 2023-06
AstraZeneca USD 5.23B 272M 2025-09
Bristol-Myers Squibb USD 4.24B 967M 2025-09
Cipla INR 12.55B 6.4B 2025-12
Clal Biotechnology ILS -5.3M 2.09M 2022-12
Compugen USD -7.89M 536K 2025-09
CSL USD 1.96B 1.27B 2025-06
Dynavax Technologies USD 35.53M 10.9M 2025-09
Eli Lilly USD 7.88B 378.1M 2025-09
Esperion Therapeutics USD -27.51M 9.5M 2023-09
GlaxoSmithKline GBP 3.36B 179M 2025-09
Grifols EUR 482.04M 7.04M 2025-09
Halozyme Therapeutics USD 248.25M 22.74M 2025-09
Ionis Pharmaceuticals USD -157.12M 307.36M 2025-09
J&J USD 9.52B 389M 2025-09
Merck USD 8.39B 1.97B 2025-09
Minerva Neurosciences USD -4.36M 1.71M 2024-09
Neurocrine Biosciences USD 246.7M 93.8M 2025-09
Novartis USD 5.88B 290M 2025-09
Novavax USD -117.12M 55.66M 2024-09
Pfizer USD 6.08B 351M 2025-09
Roche Holding CHF 12.68B 2.36B 2024-06
Sanofi EUR 4.84B 2.95B 2025-09
Takeda JPY 448.13B 173.98B 2025-12
Vanda Pharmaceuticals USD -8.31M 2.37M 2024-12


Minerva Neurosciences - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Feb 2026.